Page 2 - Eye Physicians News Today

Mexico native John C. Hagan, III, MD, an honors graduate of St. Brendan School and Mexico High School, was awarded the Kansas City Medical Society (KCMS) Lifetime Achievement Award in ceremonies Nov. …

The Platte Valley Physician-Hospital Organization (PHO) is now in-network with Medica Medicare Advantage. The enrollment period for next year runs until Dec. 7, with an effective date beginning Jan. 1,

Breaking News, Sports, Manitoba, Canada

More than three quarters of the estimated 43 million people in the world who are blind could regain sight through medical intervention. But around 90 percent of these cases of preventable blindness occur in low- and middle-income countries, which often lack the resources to perform sight-saving...

Your Guide To The Best Eye Drops For Pink Eye (Conjunctivitis)

It starts with an often-paralyzing attack on computer systems. Doctors scramble to notify patients awaiting surgery that their procedures have been delayed due to a ransomware attack. Sometimes a single cyberattack can impact hospitals across multiple states, as was the case when hackers targeted CommonSpirit Health in October 2022. Just one reported case of ransomware has […]

CHARLESTON, W.Va. — Lobbyists for some of West Virginias largest constituencies — senior citizens, natural gas producers and coal mining interests — were the largest spenders during the 2023 regular

CHARLESTON, W.Va. — Lobbyists for some of West Virginia’s largest constituencies — senior citizens, natural gas producers and coal mining interests — were the largest spenders during the 2023 regular

CHARLESTON, W.Va. — Lobbyists for some of West Virginia’s largest constituencies — senior citizens, natural gas producers and coal mining interests — were the largest spenders during the 2023 regular

Clinical trial suggests low-dose atropine is an effective myopia treatment. The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose o